Sitemap
Medical science
09/2003 Frequency of the TAFI 438 G/A and factor XIIIA Val34Leu polymorphisms in patients with objectively proven pulmonary embolism
09/2003 A tetrameric glycoprotein Ib-binding protein, agglucetin, from Formosan pit viper: structure and interaction with human platelets
09/2003 Platelet hyperactivity after statin treatment discontinuation
09/2003 Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice
09/2003 Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty
09/2003 Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2
09/2003 Shedding of active tissue factor by aortic smooth muscle cells (SMCs) undergoing apoptosis
09/2003 Patterns of use of heparins in ACS
09/2003 Matrix metalloproteinase-9 expression in post-hypoxic human brain capillary endothelial cells: H2O2 as a trigger and NF-B as a signal transducer
09/2003 Linking Research and Innovative Clinical Practice: The Story of Diabetes Mellitus
09/2003 Insulin Resistant States and Insulin Signaling
09/2003 Diabesity: An Inflammatory Metabolic Condition
09/2003 Plasma Adiponectin and Hyperglycaemia in Diabetic Patients
09/2003 Platelet Function and Acetyl-Coenzyme A Metabolism in Type 1 Diabetes Mellitus
09/2003 Oxidative Stress in Diabetes
09/2003 Carbonyl Stress and Diabetic Complications
09/2003 Chemical Modification of Proteins by Lipids in Diabetes
09/2003 Glyoxal and Methylglyoxal Levels in Diabetic Patients: Quantitative Determination by a New GC/MS Method
09/2003 Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease
09/2003 Haemoglobin A1c – A Marker for Complications of Type 2 Diabetes: The Experience from the UK Prospective Diabetes Study (UKPDS)
09/2003 Glycated Hemoglobin Standardization – National Glycohemoglobin Standardization Program (NGSP) Perspective
09/2003 Haemoglobin A1c: Analysis and Standardisation
09/2003 Point-of-Care Testing in Diabetes Mellitus
09/2003 Evaluation of Portable Blood Glucose Meters. Problems and Recommendations
09/2003 Measurements of Glucose on the Skin Surface, in Stratum Corneum and in Transcutaneous Extracts: Implications for Physiological Sampling
09/2003 Biological Variability of Albumin Excretion Rate and Albumin-to-Creatinine Ratio in Hypertensive Type 2 Diabetic Patients
09/2003 Clinical and Laboratory Evaluation of Specific Chemiluminescence Assays for Intact and Total Proinsulin
09/2003 Clinical Impact of the New Criteria for the Diagnosis of Diabetes Mellitus
09/2003 The Effect of the New ADA and WHO Guidelines on the Number of Diagnosed Cases of Diabetes
Mellitus
09/2003 Detecting Type 2 Diabetes by a Single Post-Challenge Blood Sample
09/2003 Laboratory Tests in Diagnosis and Management of Diabetes Mellitus. Practical Considerations
09/2003 Obesity, Glucose Intolerance and Diabetes and Their Links to Cardiovascular Disease. Implications for Laboratory Medicine
09/2003 Mitochondrial Oxidative Stress and Mitochondrial DNA
09/2003 The New European Directive on in vitro Diagnostics
09/2003 Two MMP-2 Promoter Polymorphisms (–790T/G and –735C/T) in Chronic Heart Failure
09/2003 A Common Truncated Variant of Lipoprotein Lipase in the Japanese Population Is Characterized by Pattern B Phenotype
09/2003 Effects of Acute, Heavy-Resistance Exercise on Urinary Peptide Hormone Excretion in Humans
09/2003 HMG-CoA Reductase Inhibitors Are Associated with Decreased Serum Neopterin Levels in Stable Coronary Artery Disease
09/2003 Impairment of Blood-Brain Barrier Integrity during Carotid Surgery as Assessed by Serum S-100B Protein Concentrations
09/2003 Characteristics of Prolidase from the Erythrocytes of Normal Humans and Patients with Prolidase Deficiency and Their Mother
09/2003 Reference Levels of Insulin-Like Growth Factor I in the Serum of Healthy Adults: Comparison of Four Immunoassays
09/2003 Age-Specific Analysis of Normal Cytokine Levels in Healthy Infants
09/2003 Differences between Genotyping and Phenotyping Methods for Assessing Apolipoprotein(a) Size Polymorphisms
09/2003 CYP3A4 and MDR1 Alleles in a Portuguese Population
09/2003 Common Variants in the Lipoprotein Lipase Gene in Brazil: Association with Lipids and Angiographically Assessed Coronary Atherosclerosis
09/2003 The Risk of Venous Thromboembolism Associated with the Factor V Leiden Mutation and Low B-Vitamin Status
09/2003 Analytical Evaluation of an Automated Immunoassay for Cardiac Troponin I: The Vidas Troponin I Assay
09/2003 Can Fluoride-Oxalate and Sodium Citrate Stabilise Homocysteine Levels after Blood Collection?
09/2003 Learning Curve of a New Hospital Laboratory. The Monitoring of Computer-Generated Turnaround Time of Laboratory Tests in an Emergency Department
10/2003 Optimal low-molecular-weight heparin regimen in major orthopaedic surgery
10/2003 Role of c-kit/Kit ligand signaling in regulating vasculogenesis
10/2003 Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and Protein Kinase A
10/2003 Sprouty proteins: antagonists of endothelial cell signaling and more
10/2003 Lymphangiogenesis and tumor metastasis
10/2003 Migration of leukocytes through the vessel wall and beyond
10/2003 Statins as novel immunomodulators: From cell to potential clinical benefit
10/2003 Induction of plasminogen activator inhibitor I by the PPAR ligand, Wy-14,643, is dependent on ERK1/2 signaling pathway
10/2003 Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis In vitro analysis using overall hemostasis potential (OHP) assay
10/2003 Homozygous and double heterozygous Factor V Leiden and Factor II G20210A genotypes predispose infants to thromboembolism but are not associated with an increase of foetal loss
10/2003 Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance
10/2003 Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis
10/2003 Stejnulxin, a novel snake C-type lectin-like protein from Trimeresurus stejnegeri venom is a potent platelet agonist acting specifically via GPVI
10/2003 Duration of exposure to high fluid shear stress is critical in shear-induced platelet activation-aggregation
10/2003 Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins
10/2003 Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns
10/2003 Circulating endothelial cells in pulmonary hypertension
10/2003 Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells
10/2003 Genetic deletion of tissue-type plasminogen activator (t-PA) in APOE3-Leiden mice reduces progression of cholesterol-induced atherosclerosis
10/2003 Plasminogen activator inhibitor-1 and outcome after femoropopliteal angioplasty: analysis of genotype and plasma levels
10/2003 Plasmin generation dependent on -enolase-type plasminogen receptor is required for myogenesis
Back
Search
